News & Articles

The AACR and the UBS oncology impact fund aim to use the new funding gift program to propel breakthroughs in cancer research and therapeutics

The new division, led by Dr. Phil Jones, aims to offer a comprehensive drug discovery service to customers

Metafora biosystems receives exceptional reimbursement for the new METAglut1 test to help diagnose De Vivo disease

The highly anticipated platform was launched by Repositive at AACR annual meeting

Earlham Institute boosts national capability in genomics and single cell analysis with ultra-high throughput sequencing platform from Illumina

New Synapsys microbiology informatics solution will be demonstrated at the event

Learn the impact of column technology design on protein RPLC

Cell picking and imaging system by Yamaha has expanded applicability, including ex vivo tissue picking

SelectScience to host a free, educational webinar on the rapid diagnosis of venous thromboembolism

NYU school of medicine becomes the most recent cancer center to join PanFAM-1 prospective study

During the American Association for Cancer Research 2018 Annual Meeting, SelectScience recognized cutting-edge products and technologies advancing life sciences research

The trial demonstrates that first-line pembrolizumab treatment improved overall and progression-free survival rates in patients with metastatic nonsquamous non-small cell lung cancer

The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer

Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer

The FT819 CAR T cell line has the potential to be mass-produced, stored, and made readily available for cancer immunotherapy